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The determination of chemical purity, melting range, and variation of enthalpy in the process of 
characterizing medicines is one of the principal requirements evaluated in quality control of the 
pharmaceutical industry. In this study, the method of purity determination using DSC was outlined, as 
well as the application of this technique for the evaluation of commercial samples of zidovudine (AZT) 
(raw material) supplied by different laboratories. To this end, samples from six different laboratories 
(A, B, C, D, E, and F) and the standard reference (R) from the United States Pharmacopeia (USP) were 
analyzed. The DSC curves were obtained in the temperature range of 25 to 200 oC under the dynamic 
atmosphere of N
2
 (50 mL min-1), heating rate of b=2 oC min-1, using an Al capsule containing approximately 
2 mg of sample material. The results demonstrated that the standard reference presented a proportion of 
99.83% whereas the AZT samples presented a variation ranging from 97.59 to 99.54%. In addition, the 
standard reference was found to present a temperature of onset of melting point of 122.80 °C. Regarding 
the samples of active agents provided by the different laboratories, a variation ranging from 118.70 to 
122.87 °C was measured. In terms of DH
m
, the samples presented an average value of 31.12 kJ mol-1.
Uniterms: Zidovudine/purity determination. Differential scanning calorimetry. Thermal analysis. 
Medicines/quality control. Medicines/qualitative analysis.
A determinação da pureza química, a faixa de fusão e a variação de entalpia envolvida no processo 
de caracterização de fármacos é um dos principais requisitos avaliados no controle de qualidade em 
indústrias farmacêuticas. Neste trabalho é feita uma breve abordagem sobre o método de determinação 
de pureza utilizando DSC, assim como a aplicação desta técnica para avaliação de amostras comerciais 
de zidovudina (AZT) (matéria-prima) fornecida por diferentes laboratórios. Para tal, foram analisadas 
amostras de seis diferentes laboratórios (A,B,C,D,E e F) e a substância química de referência (R) da 
United States Pharmacopeia (USP). As curvas DSC foram obtidas na faixa de temperatura entre 25 a 
200 oC, sob atmosfera dinâmica de N
2
 (50 mL min-1), b=2 oC min-1, utilizando cápsula de Al contendo 
aproximadamente 2 mg de amostra. De acordo com os resultados, pode-se observar que a substância 
química de referência apresentou teor igual a 99,83% e que as amostras de AZT apresentaram uma 
faixa de variação entre 97,59 e 99,54%. Pode-se verificar, ainda, que a substância química de referência 
apresentou uma temperatura onset de fusão igual a 122,80 °C. Para as amostras dos princípios ativos 
fornecidos pelos diferentes laboratórios, pode-se verificar uma faixa de variação entre 118,70 e 122,87 °C. 
No que se refere ao DH
m
, as amostras apresentaram valor médio de 31,12 kJ.mol-1.
Unitermos: Zidovudina/determinação da pureza. Calorimetria exploratória diferencial. Análise térmica. 
Medicamentos/controle de qualidade. Medicamentos/análise qualitativa.
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INTRODUCTION
Applications in the pharmaceutical field exploit 
thermal analysis as an important tool in the solution of pro-
blems involving the development, production, and quality 
control of medicines (Buckton et al., 1991). The principal 
applications in this area have included determining the 
degree of purity of drugs (Windmann, Scherrer, 1991), 
the conducting of the analyses of thermal stability and the 
kinetics of decomposition, the study of possible drug-drug 
and/or drug-excipient interactions in the pre-formulation 
phase (Iglesias et al., 1998; Saesma et al., 1991; Araújo 
et al., 2003), and in the characterization of raw materials 
and finished products (Ford, Timmins, 1989; Canotilho 
et al., 1992; Cammenga, Epple, 1995; Giron, 1998, 1999; 
Brown, Glass, 1999; Thompson, 2000).
Canotilho and collaborators (1992) reported that 
the resources and potential of thermal analysis in the 
pharmaceutical field are considerable not only for the 
study of polymorphism, but also for their versatility in 
other applications. These encompass characterization of 
polymorphs (Barbas et al., 2007), inclusion complexes and 
solid dispersants, studies of drug/drug compatibility and 
drug/excipients at the pre-formulation level (Kiss et al., 
2006), determination of chemical purity, study of reactions 
in solid state (thermal stability and kinetic parameters) 
(Araújo et al., 2005), analysis of solid dosage forms, qua-
lity control of drugs and medicines (as in the determination 
of the contents of ash and humidity, among others) (Araújo 
et al., 2006), the evaluation of isomers and polymorphs, 
the analysis of raw materials (drugs and excipients) as 
well as finished dosage forms (emulsions, suppositories, 
microspheres, pills, liposomes, powders, creams, and gels) 
(Canotilho et al., 1992; Lvova et al., 1993).
The determination of the melting point using the 
differential scanning calorimetry (DSC) method has been 
satisfactorily used as a method of evaluating the degree 
of purity of a compound (Widmann, Scherrer, 1991). By 
means of DSC, the melting range can be determined for a 
substance, and based on the equation of Van’t Hoff (Ca-
notilho et al., 1992, Bezjak et al., 1992) (Equation 1) it is 
possible to determine the molar fraction of impurities x
2 
(number of mols of impurities by the total mol number) 
contained in this material in relation to the melting range. 
However, this method can be applied only if x
2 
lies betwe-
en 0.95 and 0.999 (or 95 and 99.99 mol %). 
                              (Equation 1)
where T
m
 represents the melting temperature of impurities 
in the process of melting, since the greatest component 
of remaining crystalline solids is in equilibrium with the 
phase already melted; T
o
 is the melting temperature of the 
main component expressed in Kelvin; R is the constant 
of gases (8.3143 J K-1 mol-1); x
2
 is the molar fraction of 
impurities in liquid phase; DH
m
 is the heat of melting of 
the main component expressed in J mol-1; DH
m
 (R.T
o
2) and 
is the denominated cryoscopic constant.
When the substance is heated, the collection of im-
purities is melted, forming a liquid phase. Above this tem-
perature, the solid phase only consists of a pure substance. 
As the temperature decreases with the formation of the 
eutectic phase of impurities (Figure 1), the molar fraction 
of impurities in liquid phase x
2
 is constantly diminished 
since the pure substance dissolves in eutectic solution 
within this temperature range (Giron, Goldbronn, 1995; 
Staub, Perron, 1974). This is expressed by Equation 2:
                                                  (Equation 2)
in which x
2
* is a fraction of the impurities in the liquid 
phase of the completely melted substance or in the original 
substance, and F is the melted fraction.
When Equation 2 is substituted in Equation 1 it gives 
Equation 3. This equation describes the linear correlation 
between T
m 
and 1/F with an intercept of T
o
 and slope of 
x
2
*.R.T
o
2 /DH
m
 :
                         (Equation 3)
x
2
*– mol fraction of impurity in the original sample,
T
o 
– melting temperature of the pure main component, in K,
DH
m
 – melting heat of the pure main component in J mol-1, 
FIGURE 1 - Phase diagram of a eutectic mixture.
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F- fraction of sample melted at T
m
,
R- gas constant, 8.314 J mol-1 deg.
To obtain the graph of T
m
 x 1/F from the DSC curve, 
some points, normally within the region between 10 and 
50% of the peak, are evaluated. The fraction melted is the 
ratio of the partial area DH
i
 (measured from the beginning 
of the peak to temperature T
m
) to the total area DH
tot
. The 
range between 10 and 50% of the peak is also used to 
exclude the highest concentration of impurities in liquid 
phase and to avoid errors in the region where the rate 
of melting is also greater. If the calculated values show 
correlation among each other then the curve produced by 
T
m
 x 1/F will typically be represented by a straight line (Fi-
gure 2). The purity determination by DSC is explained by 
the theory of non-linearity, that is, the area where melting 
is normally initiated occurs due to a series of impurities 
melting before the main compound, thereby explaining 
a non-linear process. Thus, the accepted procedure for 
linearization of these data includes correction for this area 
(Blaine, Schoff, 1983). The melting temperature, melting 
heat, and purity were determined using Shimadzu TASYS 
software.
The determination of degree of purity utilizing DSC 
cannot be performed in the following situations: a) when 
the compounds decompose at the stage subsequent to 
melting; b) when the impurities form a eutectic with the 
principal component, that is, the impurities are soluble in 
the liquid phase of the principal component; c) for amor-
phous materials, since the melting peak is related to the 
variation of enthalpy in function of crystallinity; d) when 
the melting heat is independent of temperature; e) when 
other events take place close to melting point such as vola-
tization or polymorphic transition (Blaine, Schoff, 1983).
As thermal analysis has stimulated great interest 
from investigators and scientists in the last few years 
regarding studies involving the quality control of drugs 
and medicines, the objective of this study was the use of 
DSC for determining the purity of zidovudine (AZT) of 
samples provided by different pharmaceutical laboratories. 
In this study, the following parameters were determined: 
purity, temperature of onset of melting (T
onset
), variation of 
enthalpy occurring during melting, besides the effects of 
variation of mass and heating rate on the results.
MATERIAL AND METHODS
Material
The standard reference of AZT (C
10
H
13
N
5
O
4
; 
3´-azido-2,3´-dideoxythymidine) was obtained from the 
United States Pharmacopeia (lot: F, N° cat. 72450). DSC 
analyses of six AZT samples supplied by Laboratório 
Farmacêutico do Estado de Pernambuco-LAFEPE, ba-
tch AZN001, Fundação para o Remédio Popular-FURP, 
batch 22459710, Indústria Química do Estado de Goiás-
IQUEGO, batch 00100/001, Sanval Indústria Farma-
cêutica LTDA, batch AB934, Fundação Oswaldo Cruz-
Farmanguinhos, batch AZL027, and Glaxo Wellcome 
Indústria Farmacêutica, lote 9054001, were carried out. 
These samples were randomly labeled A, B, C, D, E and F. 
The standard reference of AZT was called the R product.
Methods
DSC curves were recorded in a DSC-50 cell (Shima-
dzu) using aluminum crucibles containing ~ 2 mg of sam-
ples, under dynamic nitrogen atmosphere (50 mL min-1) 
and a heating rate of 2 °C min-1 in the temperature range 
of 25 to 600 °C. The DSC cell was calibrated with indium 
(m.p. 156.6 °C; DH
m 
= 28.54 J g-1). An empty pan sealed 
with a cover pan was used as a reference sample. The 
analyses were done in triplicate.
RESULTS AND DISCUSSION
The endotherm of melting corresponds to the portion 
of the DSC curve that is far from the baseline, and, later, 
returns to it. The melting temperature, T
onset
, is defined by 
the extrapolated beginning of the curve, being defined by 
the point of intersection of the tangent with the point of 
maximum slope, on the principal side of the peak with the 
base line extrapolated. Figure 3 shows the endotherm of 
melting of AZT (reference standard) obtained at the hea-
ting rate of 2 °C min-1. The graph shows that the sample 
presents an onset temperature for melting of 122.80 °C 
with DH
m
= 31.12 kJ mol-1 and a purity of 99.83%. The 1/F 
FIGURE 2 - Temperature of melting vs. 1/F (melted fraction).
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plot shows the melting temperature T
m
 measured at several 
DH
i
 as a function of the reciprocal of the liquid fraction 1/F 
before and after the required linearization (Figure 4). This 
figure shows the melting temperature, melting heat, and 
purity obtained by Shimadzu TASYS software.
The effect of heating rate on the purity determination, 
melting point, and enthalpy of melting was conducted using 
a sample mass of about 2 mg. To perform the analysis, sam-
ple B was randomly chosen for evaluation of the effects of 
heating rate and mass. Figure 5 shows the DSC curves of 
AZT (substance A) at heating rates of 1, 2, 5, 10, and 15 °C 
min-1.This study demonstrated that the heating rate had a 
significant effect on the values obtained for purity, since the 
values of purity diminish as the heating rate increases (Table 
I). This observation can be explained by the fact that the 
Van´t Hoff equation is valid for conditions of equilibrium 
and therefore lower heating rates are recommended. 
Figure 6 depicts the DSC curve of AZT (substan-
ce A) when the mass of the sample is varied by 0.58 to 
7.44 mg, for a heating rate of 2 °C min-1. In this case, the 
degree of purity, employing different values of sample 
mass, was above 99.53%. These results show clearly that 
the purity, melting heat, and temperature for the onset of 
melting undergo small variations when the sample mass 
is changed, as shown in Table II.
The representative DSC curves for the six AZT sam-
ples provided by laboratories A, B, C, D, E, and F (Figure 
7). The determination of chemical purity of the samples 
FIGURE 3 - DSC curves of AZT (standard reference) recorded in 
a dynamic nitrogen atmosphere (50 mL min-1), and at a heating 
rate of 2 °C min-1.
FIGURE 4 - The 1/F plot provides a visual assessment of the raw 
data and linearized function.
FIGURE 5 - DSC curves of AZT (A sample) recorded in a 
dynamic nitrogen atmosphere (50 mL min-1), and at a heating 
rate of 1, 2, 5, 10 and 15 °C min-1.
TABLE I - Peak temperature and enthalpy values of AZT (A sample) at different heating rates
b (°C min-1) Purity (%) T
onset
 (°C) DH
m
 (kJ mol-1)
1 99.61 120.36 29.18
2 99.53 120.34 29.35
5 99.49 120.46 28.38
10 99.23 120.77 29.07
15 98.76 120.87 29.91
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was done based on the correction factor (corrected value) 
shown for each in Table III. Consequently, the smaller 
the correction factor used, the greater the purity of the 
material. The degree of purity, the melting temperature, 
and the DH
m 
found in the analyses by DSC for the different 
samples of AZT are described in Table III.
The results were obtained using a low heating rate 
(2 °C min-1) in order to better define the event. The data 
obtained evidences that the standard reference presented 
a degree of purity of 99.83%, and that the AZT samples 
presented a variation ranging from 97.59 to 99.54%. Gi-
ven that the standard deviation is generally used to define 
intervals around the average, the results obtained for the 
tests in triplicate by DSC were shown to be sufficiently 
consistent and with a low dispersion of values. The results 
in Table I show that the standard reference presented a 
temperature for the onset of melting of 122.80 °C. Con-
cerning the samples of active ingredients provided by the 
FIGURE 6 - DSC curves of AZT (A sample) using different 
weights recorded in a dynamic nitrogen atmosphere 
(50 mL min-1), and at a heating rate of 2 °C min-1.
TABLE II - Results of differential scanning calorimetry for AZT (A sample) at different weights.
Weight (mg) Purity (%) T
onset
 (°C) DH
m
 (kJ.mol-1)
0.580 99.59 120.38 30.64
1.120 99.49 120.41 29.12
2.710 99.58 120.47 30.57
5.050 99.53 120.14 29.60
7.440 99.48 120.04 28.69
FIGURE 7 - DSC curves of melting for different samples of 
AZT and standard reference using dynamic nitrogen atmosphere 
(50 mL min-1), and a heating rate of 2 °C min-1.
TABLE III – Purity analysis, temperature and melting heat of different samples of AZT using DSC recorded in a dynamic nitrogen 
atmosphere (50 mL min-1), and at a heating rate of 2 °C min-1
Products Purity (%) Correction factor (%) T
onset
 (°C) DH
m
 (kJ mol-1)
Standard reference 99.83 ± 0.09 7.83 122.80 ± 0.76 31.12 ± 0.61
A 99.53 ± 0.14 10.92 120.81 ± 0.12 29.43 ± 0.96
B 99.54 ± 0.28 7.91 122.87 ± 0.83 29.54 ± 0.95
C 98.43 ± 0.10 12.76 121.82 ± 0.35 30.78 ± 1.13
D 97.59 ± 0.16 18.38 118.70 ± 0.43 29.97 ± 1.38
E 98.02 ± 0.11 15.88 121.19 ± 0.42 30.45 ± 1.08
F 99.01 ± 0.12 8.28 122.32 ± 0.86 32.33 ± 0.46
A. A. S. Araújo, M. S. Bezerra, S. Storpirtis, J. R. Matos42
different laboratories, a variation of the range of melting of 
between 118.70 and 122.87°C is evident. In terms of DH
m
,, 
the samples presented an average value of 31.12 kJ mol-1.
The results obtained for product D show a greater 
proportion of impurity (2.41%) than did the remaining 
products, while a widening and shifting of the temperature 
onset of melting to a lower temperature was also observed, 
in this case to 118.70 °C.
CONCLUSION
The determination of the purity of substances by 
DSC is considered a fast and reliable technique for eutectic 
systems, in which melting is not accompanied by thermal 
decomposition of the material. The main advantages of 
the technique over chromatography and spectroscopy 
are that analysis of all the impurities normally does not 
require standards except for the main compound, and per-
mits simultaneous measurement of the melting range and 
variation of enthalpy. In this study, the comparison of six 
commercial samples of AZT medicine and the analysis of 
the chemical reference substance provided by the United 
States Pharmacopeia was conducted.
The results showed that the standard reference 
presented a proportion of 99.83% while the AZT sam-
ples presented a range of variation between 97.59 and 
99.54%. Given that standard deviation is generally used 
to define intervals around the average, the obtained 
results for the tests in triplicate by DSC show sufficient 
agreement and a low dispersion of values. This can be 
verified even though the standard reference presented 
a temperature for the onset of melting of 122.80 °C. 
For the samples of active ingredients provided by the 
different laboratories, a variation ranging from 118.70 
to 122.87 °C was ascertained. With regards to DH
m
, the 
samples presented an average value of 31.12 kJ.mol-1. In 
conclusion, the number of studies published in the last 
few years, the speed in obtaining results, and the deve-
lopment of computer calculus programs have stimulated 
this technique and shown it to be promising.
This study demonstrated that the heating rate had a 
significant effect on the values obtained for purity, since 
the values of purity diminish as the heating rate increases. 
The results show clearly that the purity, melting heat, and 
temperature for the onset of melting undergo small varia-
tions when the sample mass is changed.
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